1. Home
  2. PTHL vs INTT Comparison

PTHL vs INTT Comparison

Compare PTHL & INTT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTHL
  • INTT
  • Stock Information
  • Founded
  • PTHL 1998
  • INTT 1981
  • Country
  • PTHL China
  • INTT United States
  • Employees
  • PTHL N/A
  • INTT N/A
  • Industry
  • PTHL
  • INTT Semiconductors
  • Sector
  • PTHL
  • INTT Technology
  • Exchange
  • PTHL Nasdaq
  • INTT Nasdaq
  • Market Cap
  • PTHL 85.4M
  • INTT 77.3M
  • IPO Year
  • PTHL 2024
  • INTT 1997
  • Fundamental
  • Price
  • PTHL $18.50
  • INTT $7.20
  • Analyst Decision
  • PTHL
  • INTT Strong Buy
  • Analyst Count
  • PTHL 0
  • INTT 2
  • Target Price
  • PTHL N/A
  • INTT $12.00
  • AVG Volume (30 Days)
  • PTHL 1.0M
  • INTT 30.2K
  • Earning Date
  • PTHL 02-11-2025
  • INTT 08-01-2025
  • Dividend Yield
  • PTHL N/A
  • INTT N/A
  • EPS Growth
  • PTHL N/A
  • INTT N/A
  • EPS
  • PTHL N/A
  • INTT N/A
  • Revenue
  • PTHL $448,196.00
  • INTT $127,503,000.00
  • Revenue This Year
  • PTHL N/A
  • INTT N/A
  • Revenue Next Year
  • PTHL N/A
  • INTT $10.07
  • P/E Ratio
  • PTHL N/A
  • INTT N/A
  • Revenue Growth
  • PTHL N/A
  • INTT 5.19
  • 52 Week Low
  • PTHL $1.32
  • INTT $5.24
  • 52 Week High
  • PTHL $22.34
  • INTT $11.92
  • Technical
  • Relative Strength Index (RSI)
  • PTHL N/A
  • INTT 59.70
  • Support Level
  • PTHL N/A
  • INTT $6.73
  • Resistance Level
  • PTHL N/A
  • INTT $7.72
  • Average True Range (ATR)
  • PTHL 0.00
  • INTT 0.34
  • MACD
  • PTHL 0.00
  • INTT 0.03
  • Stochastic Oscillator
  • PTHL 0.00
  • INTT 56.00

About PTHL Pheton Holdings Ltd Class A Ordinary Shares

Pheton Holdings Ltd is a healthcare solutions provider dedicated to developing and commercializing treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a type of radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system, FTTPS, is designed to promote the efficiency, accuracy, and safety of brachytherapy. FTTPS is a user-oriented treatment planning system, or TPS, for treating a wide variety of malignant tumors, which can determine the target volume, prescription dose, and dose limitation to protect OARs and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients.

About INTT inTest Corporation

inTest Corp is a supplier of test and process solutions for use in manufacturing and testing across a range of markets including automotive, defense/aerospace, industrial, medical, semiconductor and telecommunications. The company manages its business as three operating segments which is also their reporting units that includes Electronic Test, Environmental Technologies and Process Technologies. Electronic Test (which includes semiconductor test equipment, flying probe and in-circuit testers), Environmental Technologies (which includes its thermal test, process and storage products) and Process Technologies (which includes induction heating and video imaging products). The company operates their business and sells its products both domestically and internationally.

Share on Social Networks: